Clinical Trials Logo

Filter by:
NCT ID: NCT04954677 Recruiting - Clinical trials for Magnet Controlled Capsule Endoscopy

A Real-time Quality Control System of Magnetic-controlled Capsule Gastroscopy

Start date: August 27, 2021
Phase: N/A
Study type: Interventional

With the rapid development of artificial intelligence technology, more and more deep learning technology has been applied to medicine. Our research is to develop a set of quality control system for magnetic capsule gastroscope using deep learning technology, and conduct a randomized controlled trial to verify its practical efficiency.

NCT ID: NCT04954521 Recruiting - Liver Neoplasms Clinical Trials

Anlotinib for Hepatocellular Carcinoma

AFHC
Start date: June 30, 2021
Phase:
Study type: Observational

The purpose of this study is to observe and explore the effect of single or combined treatment of arotinib on the survival and prognosis of patients with advanced liver cancer in the real world, and to summarize the treatment experience of a wide range of people.

NCT ID: NCT04954456 Recruiting - Clinical trials for Advanced Malignant Tumor

A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies

Start date: June 2, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, open label, non-randomised, dose-escalation single agent study with expansion cohorts for dose confirmation/safety and preliminary efficacy of QLS31901 in advanced or metastatic malignancies

NCT ID: NCT04954417 Recruiting - Osteoporosis Clinical Trials

A Study on Vertebral Bone Strength by Micro-CT-Like Image

Start date: May 1, 2021
Phase:
Study type: Observational

In this study, we use conditional generation adversarial network to enhance the resolution of MSCT images and obtain micro-CT-like images. Based on this, we measure the bone structure indexes of micro-CT-like images and analyzed the correlation between bone structure and bio-mechanical indexes.

NCT ID: NCT04954404 Recruiting - Clinical trials for Mitral Valve Disease

Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients With Mitral Valve Disease (TORCH-M)

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of transcatheter mitral valve intervention in Chinese population with mitral valve disease.

NCT ID: NCT04953819 Recruiting - Clinical trials for Coronary Artery Disease

Coronary Revascularization in Patients With Dialysis in China

CRUISE
Start date: November 1, 2020
Phase:
Study type: Observational [Patient Registry]

China patients in end stage renal disease receiving maintenance dialysis have a high risk of cardiovascular disease (CVD), with a prevalence of 45.5% approximately, and coronary artery disease (CAD) has been identified as the most common one. It remains unclear that what their treatment status is and whether this group of patients can benefit from revascularization in China. The investigators plan to recruit around 30 hospitals from 7 regions as study centers, which represent different levels of economic development in Mainland China. The detailed information includes demographics, medical history, coronary angiogram, in-hospital treatment and procedures, short-term and long-term outcomes. The aim of the study is to provide the real world knowledge about current status of coronary revascularization and prognosis in patients with CAD and dialysis.

NCT ID: NCT04953663 Recruiting - Stroke Clinical Trials

Clinical Plan of Ischemic Stroke

Start date: January 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Stroke is the main cause of adult health damage. 20% of stroke survivors need institutional care after 3 months, and up to 30% of them have severe or permanent disability. Stem cells are a kind of pluripotent cells with the ability of self replication. The self-renewal and differentiation characteristics of mesenchymal stem cells, as well as cytokine secretion effect and immune characteristics, provide the possibility for mesenchymal stem cells to treat ischemic stroke. After the infusion of mesenchymal stem cells, the secretion of soluble media including growth factors and cytokines may be the main mechanism of mesenchymal stem cells.

NCT ID: NCT04953624 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Appetite and Related Factors in Patients With ALS

Start date: August 1, 2020
Phase:
Study type: Observational

Chinese cnaq scale was used to evaluate the appetite changes of Chinese ALS patients; Objective to investigate the related factors of appetite changes in ALS patients; Objective to investigate the effect of anorexia on the progression and survival of ALS patients.

NCT ID: NCT04953546 Recruiting - Clinical trials for Anterior Cruciate Ligament Injuries

Clinical Application of the Apex of the Deep Cartilage in Evaluating the Femoral Tunnel of the ACL Reconstruction

Start date: June 1, 2021
Phase:
Study type: Observational

With the apex of the deep cartilage (ADC) as the symbol, the consistency of the two methods in the postoperatively computed tomography (CT) and microscopic evaluation of the position of the femoral tract of the anterior cruciate ligament (ACL) was studied.Expected results:P1 and P2, D1 and D2 were positively correlated, and the linear relationship was significant. Bland-Altman diagram shows a good consistency.

NCT ID: NCT04953533 Recruiting - Gout Clinical Trials

Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout

Start date: July 6, 2021
Phase:
Study type: Observational

To evaluate differences in specific SNPs and intestinal microflora between patients with gout and hyperuricemia and healthy controls.